Torrent Pharmaceuticals Q4 profit declines 21.9% due to acquisition costs
pre-market1 source ↓written by the desknot a recommendation
- in Q4 profit
- 21.9% decline
- due to acquisition
- ₹3.89 billion
- Total revenue rose
- 41.8%
- ₹41.97 billion
- expenses surged
- 60%
Torrent Pharmaceuticals reported a 21.9% decline in Q4 profit, falling to ₹3.89 billion due to acquisition costs from J.B. Chemicals. Total revenue rose 41.8% to ₹41.97 billion, driven by domestic formulations, but expenses surged nearly 60%. The company declared a ₹9 per share dividend.
Not investment advice. For informational purposes only.